Alberio L, Kimmerle S, Baumann A, Taleghani BM, Biasiutti FD, Lammle B. Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia. Am J Med 114:528-536, 2003.

Almedia JI, Coats R, Liem TK, Silver D. Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome. J Vasc Surg 27:309-316, 1998.

Ardlie NG, Packham MA, Mustard JF. Adenosine diphosphate-induced platelet aggregation in suspensions of washed rabbit platelets. Br J Haematol 19:7-17,1970.

Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Wolf M, Meyer D. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 68:95-96, 1992.

Amiral J, Bridey F, Wolf M, Boyer-Neumann C, Fressinaud E, Vissac AM, Peynaud-Debayle E, Dreyfus M, Meyer D. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Haemost 73:21-28, 1995.

Amiral J, Pouplard C, Vissac AM, Walenga JM, Jeske W, Gruel Y. Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation. Br J Haematol 109:336-341, 2000.

Arepally G, Reynolds C, Tomaski A, Amiral J, Jawad A, Poncz M, Cines DB. Comparison of the PF4/heparin ELISA assay with the 14C-serotonin assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 104:648-654, 1995.

Babcock RB, Dumper CW, Scharfman WB. Heparin-induced immune thrombocytope-nia. N Engl J Med 295:237-241, 1976.

Bachelot-Loza C, Saffroy R, Lasne D, Chatellier G, Aiach M, Rendu F. Importance of the FcyRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis. Thromb Haemost 79:523-528, 1998.

Bauer TL, Arepally G, Konkle BA, Mestichelli B, Shapiro SS, Cines DB, Poncz M, McNulty S, Amiral J, Hauck WW, Edie RN, Mannion JD. Prevalence of heparin-

associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 95:1242-1246, 1997.

Berube C, Mitchell L, Silverman E, David M, Saint Cyr C, Laxer R, Adams M, Vegh P, Andrew M. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study. Pediatr Res 44:351-366, 1998.

Chong BH, Ismail F, Cade J, Gallus AS, Gordon S, Chesterman CN. Heparin-induced thrombocytopenia: studies with a new molecular weight heparinoid, Org 10172. Blood 73:1592-1596, 1989.

Chong BH, Burgess J, Ismail F. The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost 69: 344-350, 1993a.

Chong BH, Pilgrim RL, Cooley MA, Chesterman CN. Increased expression of platelet IgG Fc receptors in immune heparin-induced thrombocytopenia. Blood 81:988-993, 1993b.

Chong BH, Murray B, Berndt MC, Dunlop LC, Brighton T, Chesterman CN. Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood 83: 1535-1541, 1994.

Collins JL, Aster RH, Moghaddam M, Piotrowski MA, Strauss TR, McFarland JG. Diagnostic testing for heparin-induced thrombocytopenia (HIT): and enhanced platelet factor 4 complex enzyme linked immunosorbent assay (PF4 ELISA) [abstr]. Blood 90(suppl 1): 461a, 1997.

Eichler P, Budde U, Haas S, Kroll H, Loreth RM, Meyer O, Pachmann U, Potzsch B, Schabel A, Albrecht D, Greinacher A. First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet activation test (HIPA) in comparison with a PF4/heparin ELISA. Thromb Haemost 81:625-629,1999.

Eichler P, Raschke R, Lubenow N, Meyer O, Schwind P, Greinacher A. The ID microtyping system for detection of heparin-induced antibodies in comparison with functional and antigenic assays [abstr]. Ann Hematol 80(suppl):A15, 2001.

Favaloro EJ, Bernal-Hoyos E, Exner T, Koutts J. Heparin-induced thrombocytopenia laboratory investigation and confirmation of diagnosis. Pathology 24:177-183, 1992.

Fouassier M, Bourgerette E, Libert F, Pouplard C, Marques-Verdier A. Determination of serotonin release from platelets by HPLC and ELISA in the diagnosis of heparin-induced thrombocytopenia: comparison with reference method by [14C]-serotonin release assay. J Thromb Haemost 4:1136-1139, 2006.

Francis JL, Drexler A, Duncan MK, Desai H, Amaya M, Robson T, Meyer TV, Reyes E, Rathmann K, Amirkhosravi A. Prospective evaluation of laboratory tests for the diagnosis of heparin-induced thrombocytopenia [abstr]. Blood 108:312a, 2006.

Fratantoni JC, Pollet R, Gralnick HR. Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods. Blood 45:395-401, 1975.

Ginsberg JS, Wells PS, Brill-Edwards P, Donovan D, Moffatt K, Johnston M, Stevens P, Hirsh J. Antiphospholipid antibodies and venous thromboembolism. Blood 86: 3685-3691, 1995.

Gobbi G, Mirandola P, Tazzari PL, Ricci F, Caimi L, Cacchioli A, Papa S, Conte R, Vitale M. Flow cytometry detection of serotonin content and release in resting and activated platelets. Br J Haematol 121:892-896, 2003.

Goodfellow KJ, Brown P, Malia RG, Hampton KK. A comparison of laboratory tests for the diagnosis of heparin-induced thrombocytopenia [abstr]. Br J Haematol 101(suppl 1):89,1998.

Greinacher A, Michels I, Kiefel V, Mueller-Eckhardt C. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost 66:734-736,1991.

Greinacher A, Michels I, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: the antibody is not heparin specific. Thromb Haemost 67:545-549,1992.

Greinacher A, Amiral J, Dummel V, Vissac A, Kiefel B, Mueller-Eckhardt C. Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion 34:381-385,1994a.

Greinacher A, Feigl M, Mueller-Eckhardt C. Crossreactivity studies between sera of patients with heparin associated thrombocytopenia and a new low molecular weight heparin, reviparin [letter]. Thromb Haemost 72:644-645, 1994b.

Greinacher A, Liebenhoff U, Kiefel V, Presek P, Mueller-Eckhardt C. Heparin-asso-ciated thrombocytopenia: the effects of various intravenous IgG preparations on antibody mediated platelet activation—a possible new indication for high dose i.v. IgG. Thromb Haemost 71:641-645,1994c.

Greinacher A, Gopinadhan M, Günther JU, Omer-Adam MA, Strobel U, Warkentin TE, Papastavrou G, Weitschies W, Helm CA. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies. Arterioscler Thromb Vasc Biol 26:2386-2393, 2006.

Greinacher A, Juhl D, Strobel U, Wessel A, Lubenow N, Selleng K, Eichler P, Warkentin TE. Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity, and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA classes. J Thromb Haemost 2007; in press.

Home MK III, Chao ES. Heparin binding to resting and activated platelets. Blood 74:238-243, 1989.

Horsewood P, Warkentin TE, Hayward CPM, Kelton JG. The epitope specificity of heparin-induced thrombocytopenia. Br J Haematol 95:161-167,1996.

Jeske W, Fareed J, Eschenfelder V, Iqbal O, Hoppensteadt D, Ahsan A. Biochemical and pharmacologic characteristics of reviparin, a low-molecular-mass heparin. Semin Thromb Hemost 23:119-128, 1997.

Juhl D, Eichler P Lubenow N, Strobel U, Wessel A, Greinacher A. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia. Eur J Haematol 76:420-426, 2006.

Kappa JR, Fisher CA, Berkowitz HD, Cottrell ED, Addonizio VP Jr. Heparin-induced platelet activation in sixteen surgical patients: diagnosis and management. J Vasc Surg 5:101-109, 1987.

Kapsch D, Silver D. Heparin-induced thrombocytopenia with thrombosis and hemorrhage. Arch Surg 116:1423-1427, 1981.

Kelton JG, Sheridan D, Brain H, Powers PJ, Turpie AG, Carter CJ. Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia. J Lab Clin Med 103:606-612, 1984.

Kelton JG, Sheridan D, Santos A, Smith J, Steeves K, Smith C, Brown C, Murphy WG. Heparin-induced thrombocytopenia: laboratory studies. Blood 72:925-930, 1988.

Kikta MJ, Keller MP, Humphrey PW, Silver D. Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome? Surgery 114:705-710, 1993.

Kinlough-Rathbone RL, Packham MA, Mustard JF. Platelet aggregation. In: Harker LA, Zimmerman TS, eds. Methods in Hematology: Measurements of Platelet Function. Edinburgh: Churchill Livingstone, pp. 64-91,1983.

Lee DP, Warkentin TE, Denomme GA, Hayward CPM, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry. Br J Haematol 95:724-731, 1996.

Lindhoff-Last E, Gerdsen F, Ackermann H, Bauersachs R. Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocy-topenia. Br J Haematol 113:886-890, 2001.

Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 4:759-765, 2006.

Look KA, Sahud M, Flaherty S, Zehnder JL. Heparin-induced platelet aggregation vs. platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis. Am J Clin Pathol 108:78-82, 1997.

Makhoul RG, Greenberg CS, McCann RL. Heparin-induced thrombocytopenia and thrombosis: a serious clinical problem and potential solution. J Vasc Surg 4:522-528,1986.

Meyer O, Salama A, Pittet N, Schwind P. Rapid detection of heparin-induced platelet antibodies with particle gel immunoassay (ID-HPF4). Lancet 354:1525-1526,1999.

Mustard JF, Perry DW, Ardlie NG, Packham MA. Preparation of suspensions of washed platelets from humans. Br J Haematol 22:193-204, 1972.

Nagi PK, Ackermann F, Wendt H, Savoca R, Bosshard HR. Protein A antibody-capture ELISA (PACE): an ELISA format to avoid denaturation of surface-adsorbed antigens. J Immunol Methods 158:267-276,1993.

Newman PM, Chong BH. Further characterization of antibody and antigen in heparin-induced thrombocytopenia. Br J Haematol 107:303-309,1999.

Newman PM, Swanson RL, Chong BH. Heparin-induced thrombocytopenia: IgG binding to PF4-heparin complexes in the fluid phase and cross-reactivity with low molecular weight heparin and heparinoid. Thromb Haemost 80:292-297, 1998.

Nguyen P, Lecompte T, and Groupe d'Etude sur l'Hemostase et la Thromboses (GEHT) de la Societe Franchise d'Hematologie. Nouv Rev Fr Hematol 36:353-357, 1994.

Nguyen P, Droulle C, Potron G. Comparison between platelet factor 4/heparin complexes ELISA and platelet aggregation test in heparin-induced thrombocytope-nia [letter]. Thromb Haemost 74:793-810,1995.

Packham MA, Guccione MA, Perry DW. ADP does not release platelet granule contents in a plasma-free system [abstr]. Fed Proc 30:201,1971.

Pengo V, Biasiolo A, Fior MG. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when p2-glycoprotein I is bound to a suitable surface. Thromb Haemost 73:29-34, 1995.

Pfueller SL, David R. Different platelet specificities of heparin-dependent platelet aggregating factors in heparin-induced thrombocytopenia. Br J Haematol 64:149159,1986.

Polgar J, Eichler P, Greinacher A, Clemetson KJ. Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients. Blood 91:549-554, 1998.

Pötzsch B, Keller M, Madlener K, Müller-Berghaus G. The use of heparinase improves the specificity of crossreactivity testing in heparin-induced thrombocytopenia [letter]. Thromb Haemost 76:1118-1122, 1996.

Pouplard C, Amiral J, Borg JY, Vissac AM, Delahousse B, Gruel Y. Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocy-topenia and consequences on cross-reactivity with danaparoid sodium. Br J Haematol 99:273-280,1997.

Pouplard C, Amiral J, Borg JY, Laporte-Simitsidis S, Delahousse B, Gruel Y. Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 111:700-706,1999.

Prechel MM, McDonald MK, Jeske WP, Messmore HL, Walenga JM. Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparin J Thromb Haemost 3: 2168-2175, 2005.

Rauova L, Zhai L, Kowalska MA. Aepally GM, Cines DB, Poncz M. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications. Blood 107:2346-2353, 2006.

Refaai MA, Laposata M, Van Cott EM. Clinical significance of a borderline titer in a negative ELISA test for heparin-induced thrombocytopenia Am J Clin Pathol 1l9: 6l-65, 2003.

Rhodes GR, Dixon RH, Silver D. Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations. Surg Gynecol Obstet 136:409-416, 1973.

Risch L, Bertschmann W, Heijnen IAFM, Huber AR. A differentiated approach to assess the diagnostic usefulness of a rapid particle gel immunoassay for the detection of antibodies against heparin-platelet factor 4 in cardiac surgery patients. Blood Coagul Fibrinolysis 14:99-106, 2003.

Rugeri L, Bauters A, Trillot N, Susen S, Decoen C, Watel A, Jude B. Clinical usefulness of combined use of platelet aggregation test and anti PF4-H antibodies ELISA test for the diagnosis of heparin-induced thrombocytopenia. Hematology 4:367-372,1999.

Salem HH, van der Weyden MB. Heparin-induced thrombocytopenia. Variable platelet-rich plasma reactivity to heparin dependent platelet aggregating factor. Pathology 15:297-299, 1983.

Salzman EW, Rosenberg RD, Smith MH, Lindon JN, Favreau L. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 65:64-73, 1980.

Schenk S, El-Banayosy A, Prohaska W, Arusoglu L, Morshuis M, Koester-Eiserfunke W, Kizner L, Murray E, Eichler P, Koerfer R, Greinacher A. Heparin-induced thrombocytopenia in patients receiving circulatory support. J Thorac Cardiovasc Surg 131:1373-1381, 2006.

Schenk S, El-Banayosy A, Morshuis M, Arusoglu L Eichler P, Lubenow N, Tenderich G, Koerfer R, Greinacher A, Prohaska W. IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support. J Thromb Haemost 5:235-241, 2007.

Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytope-nia. Blood 67:27-30, 1986.

Smith CA, Warkentin AE, Warkentin TE, Arnold DM, Moore JC, Kelton JG. An algorithm for "indeterminate" test results in the platelet serotonin release assay for heparin-induced thrombocytopenia (HIT) [abstr]. Blood 108:312a, 2006.

Stewart MW, Etches WS, Boshkov LK, Gordon PA. Heparin-induced thrombocytope-nia: an improved method of detection based on lumi-aggregometry. Br J Haematol 91:173-177, 1995.

Teitel JM, Gross P, Blake P, Garvey MB. A bioluminescent adenosine nucleotide release assay for the diagnosis of heparin-induced thrombocytopenia [letter]. Thromb Haemost 76:479, 1996.

Tomer A. A sensitive and specific functional flow cytometric assay for the diagnosis of heparin-induced thrombocytopenia. Br J Haematol 98:648-656, 1997.

Tomer A, Masalunga C, Abshire TC. Determination of heparin-induced thrombocyto-penia: a rapid flow cytometric assay for direct demonstration of antibody-mediated platelet activation. Am J Hematol 61:53-61, 1999.

Untch B, Ahmad S, Jeske WP, Messmore HL, Hoppensteadt DA, Walenga JM, Lietz H, Fareed J. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. Thromb Res 105:117-123, 2002.

Visentin GP, Ford SE, Scott JP, Aster RH. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 93:81-88,1994.

Visentin GP, Moghaddam M, Beery SE, McFarland JG, Aster RH. Heparin is not required for detection of antibodies associated with heparin-induced thrombocyto-penia/thrombosis. J Lab Clin Med 138:22-31, 2001.

Vitale M, Tazzari P, Ricci F, Mazza MA, Zauli G, Martini G, Caimi L, Manzoli FA, Conte R. Comparison between different laboratory tests for the detection and prevention of heparin-induced thrombocytopenia Cytometry 46:290-295, 2001.

Vun CH, Evans S, Chong BH. Cross-reactivity study of low molecular weight heparin and heparinoid in heparin-induced thrombocytopenia. Thromb Res 81:525-532,1996.

Walenga JM, Jeske WP, Fasanella AR, Wood JJ, Ahmad S, Bakhos M. Laboratory diagnosis of heparin-induced thrombocytopenia. Clin Appl Thrombosis/Hemostasis 5(suppl 1):S21-S27,1999.

Wang L, Huhle G, Malsch R, Hoffmann U, Song X, Harenberg J. Determination of heparin-induced IgG antibody by fluorescence-linked immunofiltration assay (FLIFA). J Immunol Meth 222:93-99, 1999a.

Wang L, Huhle G, Malsch R, Hoffmann U, Song X, Harenberg J. Determination of heparin-induced IgG antibody in heparin-induced thrombocytopenia type II. Eur J Clin Invest 29:232-237, 1999b.

Warkentin TE. Danaparoid (Orgaran) for the treatment of heparin-induced thrombocy-topenia (HIT) and thrombosis: effects on in vivo thrombin and cross-linked fibrin generation, and evaluation of the clinical significance of in vitro cross-reactivity (XR) of danaparoid for HIT-IgG [abstr]. Blood 88(suppl 1):626a, 1996.

Warkentin TE. Laboratory testing for heparin-induced thrombocytopenia. J Thromb Thrombolysis 10:S35-S45, 2000.

Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 121:535-555, 2003a.

Warkentin TE. Platelet count monitoring and laboratory testing for heparin-induced thrombocytopenia [letter]. Arch Pathol Lab Med 127:783, 2003b.

Warkentin TE. New approaches to the diagnosis of heparin-induced thrombocytope-nia. Chest 127 (2 suppl):35S-45S, 2005.

Warkentin TE, Heddle NM. Laboratory diagnosis of immune heparin-induced throm-bocytopenia. Curr Hematol Rep 2:148-157, 2003.

Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 135:502-506, 2001.

Warkentin TE, Sheppard JI Testing for heparin-induced thrombocytopenia antibodies. Transfus Med Rev 20:259-272, 2006a.

Warkentin TE, Sheppard JI No significant improvement in diagnostic specificity of an anti-PF4/polyanion immunoassay with use of high heparin confirmatory procedure. J Thromb Haemost 4:281-282, 2006b.

Warkentin TE, Hayward CPM, Smith CA, Kelly PM, Kelton JG. Determinants of platelet variability when testing for heparin-induced thrombocytopenia. J Lab Clin Med 120:371-379, 1992.

Warkentin TE, Hayward CPM, Boshkov LK, Santos AV, Sheppard JI, Bode AP, Kelton JG. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 84:3691-3699, 1994.

Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332:1330-1335, 1995.

Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 79:1-7, 1998.

Warkentin TE, Sheppard JI, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 96:1703-1708, 2000.

Warkentin TE, Sheppard JA, Moore JC, Moore KM, Sigouin CS, Kelton JG. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need? J Lab Clin Med 146:341-346, 2005a.

Warkentin TE, Cook RJ Marder VJ, Sheppard JI Moore JC Eriksson BI Greinacher A, Kelton JG. Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin. Blood 106:3791-3796, 2005b.

White MM, Siders L, Jennings LK, White FL. The effect of residual heparin on the interpretation of heparin-induced platelet aggregation in the diagnosis of heparin-associated thrombocytopenia [letter]. Thromb Haemost 68:88, 1992.

Zwicker JI, Uhl L, Huang WY, Shaz BH, Baucer KA. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. Thromb Haemost 2:2133-2137, 2004.

0 0

Post a comment